Global Insulin Delivery Devices Market Research Report 2021

Global Insulin Delivery Devices Market Research Report 2021

Table of Contents
1 Insulin Delivery Devices Market Overview
1.1 Product Overview and Scope of Insulin Delivery Devices
1.2 Insulin Delivery Devices Segment by Type
1.2.1 Global Insulin Delivery Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Insulin Pens
1.2.3 Insulin Pumps
1.2.4 Insulin Syringes
1.2.5 Others
1.3 Insulin Delivery Devices Segment by Application
1.3.1 Insulin Delivery Devices Sales Comparison by Application: (2021-2027)
1.3.2 Patients/Homecare
1.3.3 Hospitals & Clinics
1.4 Global Insulin Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Insulin Delivery Devices Revenue 2016-2027
1.4.2 Global Insulin Delivery Devices Sales 2016-2027
1.4.3 Insulin Delivery Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Insulin Delivery Devices Market Competition by Manufacturers
2.1 Global Insulin Delivery Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Insulin Delivery Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Insulin Delivery Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Insulin Delivery Devices Manufacturing Sites, Area Served, Product Type
2.5 Insulin Delivery Devices Market Competitive Situation and Trends
2.5.1 Insulin Delivery Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Insulin Delivery Devices Players Market Share by Revenue
2.5.3 Global Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Delivery Devices Retrospective Market Scenario by Region
3.1 Global Insulin Delivery Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Insulin Delivery Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Insulin Delivery Devices Market Facts & Figures by Country
3.3.1 North America Insulin Delivery Devices Sales by Country
3.3.2 North America Insulin Delivery Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Insulin Delivery Devices Market Facts & Figures by Country
3.4.1 Europe Insulin Delivery Devices Sales by Country
3.4.2 Europe Insulin Delivery Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Insulin Delivery Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Insulin Delivery Devices Sales by Region
3.5.2 Asia Pacific Insulin Delivery Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Insulin Delivery Devices Market Facts & Figures by Country
3.6.1 Latin America Insulin Delivery Devices Sales by Country
3.6.2 Latin America Insulin Delivery Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Insulin Delivery Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Insulin Delivery Devices Sales by Country
3.7.2 Middle East and Africa Insulin Delivery Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Insulin Delivery Devices Historic Market Analysis by Type
4.1 Global Insulin Delivery Devices Sales Market Share by Type (2016-2021)
4.2 Global Insulin Delivery Devices Revenue Market Share by Type (2016-2021)
4.3 Global Insulin Delivery Devices Price by Type (2016-2021)
5 Global Insulin Delivery Devices Historic Market Analysis by Application
5.1 Global Insulin Delivery Devices Sales Market Share by Application (2016-2021)
5.2 Global Insulin Delivery Devices Revenue Market Share by Application (2016-2021)
5.3 Global Insulin Delivery Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novo Nordisk Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 BD Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eli Lilly Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Corporation Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Medtronic Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Animas
6.6.1 Animas Corporation Information
6.6.2 Animas Description and Business Overview
6.6.3 Animas Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Animas Product Portfolio
6.6.5 Animas Recent Developments/Updates
6.7 Beta Bionics
6.6.1 Beta Bionics Corporation Information
6.6.2 Beta Bionics Description and Business Overview
6.6.3 Beta Bionics Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Beta Bionics Product Portfolio
6.7.5 Beta Bionics Recent Developments/Updates
6.8 Cellnovo
6.8.1 Cellnovo Corporation Information
6.8.2 Cellnovo Description and Business Overview
6.8.3 Cellnovo Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Cellnovo Product Portfolio
6.8.5 Cellnovo Recent Developments/Updates
6.9 Copernicus
6.9.1 Copernicus Corporation Information
6.9.2 Copernicus Description and Business Overview
6.9.3 Copernicus Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Copernicus Product Portfolio
6.9.5 Copernicus Recent Developments/Updates
6.10 Dance Biopharm
6.10.1 Dance Biopharm Corporation Information
6.10.2 Dance Biopharm Description and Business Overview
6.10.3 Dance Biopharm Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Dance Biopharm Product Portfolio
6.10.5 Dance Biopharm Recent Developments/Updates
6.11 Debiotech
6.11.1 Debiotech Corporation Information
6.11.2 Debiotech Insulin Delivery Devices Description and Business Overview
6.11.3 Debiotech Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Debiotech Product Portfolio
6.11.5 Debiotech Recent Developments/Updates
6.12 Insulet
6.12.1 Insulet Corporation Information
6.12.2 Insulet Insulin Delivery Devices Description and Business Overview
6.12.3 Insulet Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Insulet Product Portfolio
6.12.5 Insulet Recent Developments/Updates
6.13 MannKind
6.13.1 MannKind Corporation Information
6.13.2 MannKind Insulin Delivery Devices Description and Business Overview
6.13.3 MannKind Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 MannKind Product Portfolio
6.13.5 MannKind Recent Developments/Updates
6.14 Owen Mumford
6.14.1 Owen Mumford Corporation Information
6.14.2 Owen Mumford Insulin Delivery Devices Description and Business Overview
6.14.3 Owen Mumford Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Owen Mumford Product Portfolio
6.14.5 Owen Mumford Recent Developments/Updates
6.15 Roche
6.15.1 Roche Corporation Information
6.15.2 Roche Insulin Delivery Devices Description and Business Overview
6.15.3 Roche Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Roche Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 SOOIL
6.16.1 SOOIL Corporation Information
6.16.2 SOOIL Insulin Delivery Devices Description and Business Overview
6.16.3 SOOIL Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.16.4 SOOIL Product Portfolio
6.16.5 SOOIL Recent Developments/Updates
6.17 Tandem Diabetes Care
6.17.1 Tandem Diabetes Care Corporation Information
6.17.2 Tandem Diabetes Care Insulin Delivery Devices Description and Business Overview
6.17.3 Tandem Diabetes Care Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Tandem Diabetes Care Product Portfolio
6.17.5 Tandem Diabetes Care Recent Developments/Updates
6.18 Valeritas
6.18.1 Valeritas Corporation Information
6.18.2 Valeritas Insulin Delivery Devices Description and Business Overview
6.18.3 Valeritas Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Valeritas Product Portfolio
6.18.5 Valeritas Recent Developments/Updates
6.19 West Pharma
6.19.1 West Pharma Corporation Information
6.19.2 West Pharma Insulin Delivery Devices Description and Business Overview
6.19.3 West Pharma Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.19.4 West Pharma Product Portfolio
6.19.5 West Pharma Recent Developments/Updates
6.20 Ypsomed
6.20.1 Ypsomed Corporation Information
6.20.2 Ypsomed Insulin Delivery Devices Description and Business Overview
6.20.3 Ypsomed Insulin Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Ypsomed Product Portfolio
6.20.5 Ypsomed Recent Developments/Updates
7 Insulin Delivery Devices Manufacturing Cost Analysis
7.1 Insulin Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Insulin Delivery Devices
7.4 Insulin Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Insulin Delivery Devices Distributors List
8.3 Insulin Delivery Devices Customers
9 Insulin Delivery Devices Market Dynamics
9.1 Insulin Delivery Devices Industry Trends
9.2 Insulin Delivery Devices Growth Drivers
9.3 Insulin Delivery Devices Market Challenges
9.4 Insulin Delivery Devices Market Restraints
10 Global Market Forecast
10.1 Insulin Delivery Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Insulin Delivery Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Insulin Delivery Devices by Type (2022-2027)
10.2 Insulin Delivery Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Insulin Delivery Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Insulin Delivery Devices by Application (2022-2027)
10.3 Insulin Delivery Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Insulin Delivery Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Insulin Delivery Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Insulin Delivery Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Insulin Delivery Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Insulin Delivery Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Insulin Delivery Devices Covered in This Study
Table 5. Global Insulin Delivery Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Insulin Delivery Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Insulin Delivery Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Insulin Delivery Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Insulin Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Insulin Delivery Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Insulin Delivery Devices Product Type
Table 12. Global Insulin Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Insulin Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Delivery Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Insulin Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Insulin Delivery Devices Sales Market Share by Region (2016-2021)
Table 17. Global Insulin Delivery Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Insulin Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Insulin Delivery Devices Sales Market Share by Country (2016-2021)
Table 20. North America Insulin Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Insulin Delivery Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Insulin Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Insulin Delivery Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Insulin Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Insulin Delivery Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Insulin Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Insulin Delivery Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Insulin Delivery Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Insulin Delivery Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Insulin Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Insulin Delivery Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Insulin Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Insulin Delivery Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Insulin Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Insulin Delivery Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Insulin Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Insulin Delivery Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Insulin Delivery Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Insulin Delivery Devices Sales Market Share by Type (2016-2021)
Table 40. Global Insulin Delivery Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Insulin Delivery Devices Revenue Share by Type (2016-2021)
Table 42. Global Insulin Delivery Devices Price (USD/Unit) by Type (2016-2021)
Table 43. Global Insulin Delivery Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Insulin Delivery Devices Sales Market Share by Application (2016-2021)
Table 45. Global Insulin Delivery Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Insulin Delivery Devices Revenue Share by Application (2016-2021)
Table 47. Global Insulin Delivery Devices Price (USD/Unit) by Application (2016-2021)
Table 48. Novo Nordisk Corporation Information
Table 49. Novo Nordisk Description and Business Overview
Table 50. Novo Nordisk Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Novo Nordisk Insulin Delivery Devices Product
Table 52. Novo Nordisk Recent Developments/Updates
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Business Overview
Table 55. Sanofi Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Sanofi Insulin Delivery Devices Product
Table 57. Sanofi Recent Developments/Updates
Table 58. BD Corporation Information
Table 59. BD Description and Business Overview
Table 60. BD Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. BD Insulin Delivery Devices Product
Table 62. BD Recent Developments/Updates
Table 63. Eli Lilly Corporation Information
Table 64. Eli Lilly Description and Business Overview
Table 65. Eli Lilly Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Eli Lilly Insulin Delivery Devices Product
Table 67. Eli Lilly Recent Developments/Updates
Table 68. Medtronic Corporation Information
Table 69. Medtronic Description and Business Overview
Table 70. Medtronic Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Medtronic Insulin Delivery Devices Product
Table 72. Medtronic Recent Developments/Updates
Table 73. Animas Corporation Information
Table 74. Animas Description and Business Overview
Table 75. Animas Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Animas Insulin Delivery Devices Product
Table 77. Animas Recent Developments/Updates
Table 78. Beta Bionics Corporation Information
Table 79. Beta Bionics Description and Business Overview
Table 80. Beta Bionics Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Beta Bionics Insulin Delivery Devices Product
Table 82. Beta Bionics Recent Developments/Updates
Table 83. Cellnovo Corporation Information
Table 84. Cellnovo Description and Business Overview
Table 85. Cellnovo Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Cellnovo Insulin Delivery Devices Product
Table 87. Cellnovo Recent Developments/Updates
Table 88. Copernicus Corporation Information
Table 89. Copernicus Description and Business Overview
Table 90. Copernicus Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Copernicus Insulin Delivery Devices Product
Table 92. Copernicus Recent Developments/Updates
Table 93. Dance Biopharm Corporation Information
Table 94. Dance Biopharm Description and Business Overview
Table 95. Dance Biopharm Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Dance Biopharm Insulin Delivery Devices Product
Table 97. Dance Biopharm Recent Developments/Updates
Table 98. Debiotech Corporation Information
Table 99. Debiotech Description and Business Overview
Table 100. Debiotech Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Debiotech Insulin Delivery Devices Product
Table 102. Debiotech Recent Developments/Updates
Table 103. Insulet Corporation Information
Table 104. Insulet Description and Business Overview
Table 105. Insulet Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Insulet Insulin Delivery Devices Product
Table 107. Insulet Recent Developments/Updates
Table 108. MannKind Corporation Information
Table 109. MannKind Description and Business Overview
Table 110. MannKind Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. MannKind Insulin Delivery Devices Product
Table 112. MannKind Recent Developments/Updates
Table 113. Owen Mumford Corporation Information
Table 114. Owen Mumford Description and Business Overview
Table 115. Owen Mumford Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Owen Mumford Insulin Delivery Devices Product
Table 117. Owen Mumford Recent Developments/Updates
Table 118. Roche Corporation Information
Table 119. Roche Description and Business Overview
Table 120. Roche Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Roche Insulin Delivery Devices Product
Table 122. Roche Recent Developments/Updates
Table 123. SOOIL Corporation Information
Table 124. SOOIL Description and Business Overview
Table 125. SOOIL Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. SOOIL Insulin Delivery Devices Product
Table 127. SOOIL Recent Developments/Updates
Table 128. Tandem Diabetes Care Corporation Information
Table 129. Tandem Diabetes Care Description and Business Overview
Table 130. Tandem Diabetes Care Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Tandem Diabetes Care Insulin Delivery Devices Product
Table 132. Tandem Diabetes Care Recent Developments/Updates
Table 133. Valeritas Corporation Information
Table 134. Valeritas Description and Business Overview
Table 135. Valeritas Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Valeritas Insulin Delivery Devices Product
Table 137. Valeritas Recent Developments/Updates
Table 138. West Pharma Corporation Information
Table 139. West Pharma Description and Business Overview
Table 140. West Pharma Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. West Pharma Insulin Delivery Devices Product
Table 142. West Pharma Recent Developments/Updates
Table 143. Ypsomed Corporation Information
Table 144. Ypsomed Description and Business Overview
Table 145. Ypsomed Insulin Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Ypsomed Insulin Delivery Devices Product
Table 147. Ypsomed Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Insulin Delivery Devices Distributors List
Table 151. Insulin Delivery Devices Customers List
Table 152. Insulin Delivery Devices Market Trends
Table 153. Insulin Delivery Devices Growth Drivers
Table 154. Insulin Delivery Devices Market Restraints
Table 155. Global Insulin Delivery Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 156. Global Insulin Delivery Devices Sales Market Share Forecast by Type (2022-2027)
Table 157. Global Insulin Delivery Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 158. Global Insulin Delivery Devices Revenue Market Share Forecast by Type (2022-2027)
Table 159. Global Insulin Delivery Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 160. Global Insulin Delivery Devices Sales Market Share Forecast by Application (2022-2027)
Table 161. Global Insulin Delivery Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 162. Global Insulin Delivery Devices Revenue Market Share Forecast by Application (2022-2027)
Table 163. Global Insulin Delivery Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 164. Global Insulin Delivery Devices Sales Market Share Forecast by Region (2022-2027)
Table 165. Global Insulin Delivery Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 166. Global Insulin Delivery Devices Revenue Market Share Forecast by Region (2022-2027)
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Delivery Devices
Figure 2. Global Insulin Delivery Devices Market Share by Type in 2020 & 2027
Figure 3. Insulin Pens Product Picture
Figure 4. Insulin Pumps Product Picture
Figure 5. Insulin Syringes Product Picture
Figure 6. Others Product Picture
Figure 7. Global Insulin Delivery Devices Market Share by Application in 2020 & 2027
Figure 8. Patients/Homecare
Figure 9. Hospitals & Clinics
Figure 10. Global Insulin Delivery Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Insulin Delivery Devices Market Size 2016-2027 (US$ Million)
Figure 12. Global Insulin Delivery Devices Sales 2016-2027 (K Units)
Figure 13. Global Insulin Delivery Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Insulin Delivery Devices Sales Share by Manufacturers in 2020
Figure 15. Global Insulin Delivery Devices Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Insulin Delivery Devices Players: Market Share by Revenue in 2020
Figure 17. Insulin Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Insulin Delivery Devices Sales Market Share by Region (2016-2021)
Figure 19. Global Insulin Delivery Devices Sales Market Share by Region in 2020
Figure 20. Global Insulin Delivery Devices Revenue Market Share by Region (2016-2021)
Figure 21. Global Insulin Delivery Devices Revenue Market Share by Region in 2020
Figure 22. U.S. Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Insulin Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Insulin Delivery Devices by Type (2016-2021)
Figure 47. Sales Market Share of Insulin Delivery Devices by Application (2016-2021)
Figure 48. Sales Market Share of Insulin Delivery Devices by Application in 2020
Figure 49. Revenue Share of Insulin Delivery Devices by Application (2016-2021)
Figure 50. Revenue Share of Insulin Delivery Devices by Application in 2020
Figure 51. Manufacturing Cost Structure of Insulin Delivery Devices
Figure 52. Manufacturing Process Analysis of Insulin Delivery Devices
Figure 53. Insulin Delivery Devices Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Non-Invasive Glucose Meter Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79

This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......

Global Glucose Meter Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106

Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......

Global Blood Glucose Testing Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101

Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......

Global Glucose Biosensors Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139

According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......

Global Artificial Pancreas Devices Systems Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100

According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......

Global Blood Glucose Testing Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130

According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......

Global Lancing Devices Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......

Global Non-Invasive Glucose Meter Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......

Global Glucose Meter Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs